Healthtech Startups

Mesenbio develops extracellular vesicle (EV) therapeutics derived from mesenchymal stem cells, using its FT-01 platform to enable scalable, GMP-ready EV manufacturing for regenerative medicine. The company is advancing a licensing-ready production platform and preclinical therapeutic candidate (MEV-N01) targeting rheumatoid arthritis.

1 investor

DARA's Result Interpretation Module provides a digitalized workflow that replaces manual document handling processes for specialists, eliminating printing, scanning, email distribution, and courier services in healthcare result management.

1 investor

Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures. The company advances agonist antibody programs and operates a RAFT target discovery platform to identify new therapeutic targets.

1 investor

Mestag Therapeutics is an immunology company developing first-in-class agonist antibody therapies for cancer and inflammatory diseases based on fibroblast biology, and operates a RAFT platform for discovering new drug targets. It advances its own pipeline while partnering with pharmaceutical companies such as MSD and Johnson & Johnson.

1 investor

META-BIOMED manufactures biodegradable surgical sutures, dental products, and bone restoration materials for orthopedic applications, serving healthcare providers globally. The company operates as a technology-intensive medical device manufacturer with products exported to over 80 countries.

1 investor

Meta-Flux builds in silico simulation software that models disease biology — cellular state, perturbation response, and therapeutic intervention — using mechanistic models grounded in public reference atlases and proprietary multi-omic data from partner biobanks. The platform targets drug discovery in neurodegeneration (Parkinson's, Alzheimer's, ALS, MSA) and immuno-oncology (breast, lung, melanoma, colorectal) to improve target selection and patient stratification.

1 investor

Metabelly produces prebiotic dietary fiber supplements made from corn starch that support healthy gut microbiota and digestive function. The product is marketed as a neutral-tasting daily fiber source for consumers seeking to maintain gut health and satiety.

1 investor

Metabolic sells a grass-fed whey protein powder supplement formulated with collagen peptides and electrolytes, marketed for fitness, recovery, and general wellness. The product is positioned as a premium alternative to mass-market protein powders, sourced from hormone- and antibiotic-free Australian cows.

1 investor

Metabolic Insights (Mii) has developed a rapid, non-invasive insulin test designed to measure metabolic markers without lab work or a separate reader. The product targets consumers seeking at-home insight into their metabolism and metabolic health.

1 investor

Metabolic Psychiatry Labs offers mental health treatment that addresses root causes in the brain and body, targeting conditions like depression, anxiety, and bipolar disorder through metabolic interventions including nutrition, insulin resistance management, and inflammation reduction. The service delivers personalized remote clinical care using at-home monitoring devices and a digital platform.

1 investor

MetaGen provides personalized healthcare approaches based on gut microbiome analysis using proprietary metabologenomics methods. The company develops services and products that enable individuals to optimize their health by understanding and managing their unique gut microbiome composition.

1 investor

metaLead develops medications for treating metal-related diseases using chelation therapy, targeting improved patient quality of life. The company aims to establish its therapies as first-line treatments for various conditions.

1 investor

MetalloBio is an antimicrobials development company creating a new class of metal-based, broad-spectrum antibacterial agents to treat drug-resistant "superbug" infections. Its lead KLS-1 series targets complicated infections while its KLS-2 series is tuned for antimicrobial coatings on medical equipment such as catheters and joint implants.

1 investor

metasThera develops drugs targeting metastatic cancer cells by focusing on the cancer-specific plasma membrane citrate transporter pmCiC, which plays a role in cancer metabolism and adaptation.

1 investor

Metavention is developing a treatment that targets the sympathetic nervous system to disrupt overactive nerves believed to contribute to high blood pressure and other metabolic diseases. The company works on a medical intervention for hypertension and related metabolic conditions.

1 investor

Method Surgical AI develops an ultrasound imaging platform for surgical guidance that uses AI to generate real-time 3D subsurface maps for surgeons, designed to improve outcomes in robotic and minimally invasive cancer surgery.

1 investor

Metric Medical Devices develops internal bone fixation implants designed to accelerate healing and reduce non-union complications in orthopedic extremity procedures.

1 investor

Metricwire provides mobile data collection and digital monitoring solutions for clinical research and trials. The platform enables researchers to gather real-world evidence through adaptive protocols while maintaining participant engagement and safety during studies.

1 investor

Metro Vein Centers provides minimally invasive vein treatments using state-of-the-art, ultrasound-guided technology performed by board-certified vein specialists. The practice serves patients seeking personalized treatment plans for venous conditions with a focus on patient-centered care and outcomes.

1 investor

Metrodora is a venture capital firm that invests in companies working to change how people access care, skills, or information, with a focus on health care startups. Its portfolio includes companies in AI-driven drug development, women's telehealth, and senior care.

1 investor

Meu Pet Club is a Brazilian pet health insurance provider offering reimbursement-based plans that let owners choose any veterinarian, with tiered monthly plans covering consultations, exams, surgeries, and 24h veterinary telemedicine. It serves individual pet owners and companies (as a corporate employee benefit) with nationwide coverage across Brazil.

1 investor

Meyra Group is a European manufacturer of wheelchairs and medical mobility supplies. The company serves patients and healthcare systems requiring assistive devices and mobility solutions.

1 investor

MFH Saúde - My Family Health is a family medicine clinic in Portugal offering personalized medical care with ongoing patient follow-up, focused on general practice and prevention for families. Its team has decades of experience handling clinical cases across national and international health institutions.

1 investor

MGA Homecare provides in-home healthcare services, including nursing and therapy, matching patients and their families with clinicians suited to their needs. It serves individuals requiring home-based clinical care, including children with physical challenges.

1 investor